aml

Showing NaN - NaN of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

AML Trial in Puerto Rico, United States (Cytarabine (Phase 1 only), Lintuzumab-Ac225, Furosemide (Phase 1 only))

Completed
  • AML
  • Cytarabine (Phase 1 only)
  • +3 more
  • Los Angeles, California
  • +16 more
Feb 22, 2022

MDS, CMML, AML Trial in Canada, United States (SGI-110)

Completed
  • MDS
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Apr 16, 2021

AML Trial in Worldwide (Quizartinib, Salvage Chemotherapy)

Completed
  • AML
  • Duarte, California
  • +130 more
Feb 2, 2021

Myeloid Leukemias, AML, Leukemia Trial in Philadelphia (Rapamycin, Mitoxantrone, Etoposide, Cytarabine, Rapamycin + MEC)

Completed
  • Myeloid Leukemias
  • +3 more
  • Rapamycin, Mitoxantrone, Etoposide, Cytarabine
  • Rapamycin + MEC
  • Philadelphia, Pennsylvania
    University of Pennsylvania Abramson Cancer Center
Jul 10, 2019

AML Trial in Philadelphia (Sirolimus, Mitoxantrone, Etoposide)

Completed
  • AML
  • Philadelphia, Pennsylvania
  • +1 more
Oct 19, 2016

Hematologic Malignancy, Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (radiation, biological, drug)

Terminated
  • Hematologic Malignancy
  • +11 more
  • Total Body Irradiation (TBI)
  • +5 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Oct 19, 2016

CML, AML, MDS Trial in Philadelphia (Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells, Observation Arm)

Completed
  • CML
  • +6 more
  • Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells
  • Observation Arm
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 17, 2016

AML, Acute Myeloid Leukemia Trial in Philadelphia (Bexarotene)

Completed
  • AML
  • Acute Myeloid Leukemia
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of University of Pennsylvania
Jun 7, 2016